Aldeyra Therapeutics Statistics

Total Valuation

FRA:137 has a market cap or net worth of EUR 271.18 million. The enterprise value is 219.78 million.

Market Cap	271.18M
Enterprise Value	219.78M

Important Dates

The next estimated earnings date is Thursday, March 5, 2026.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	60.16M
Shares Outstanding	n/a
Shares Change (YoY)	+0.88%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	48.31%
Float	47.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	6.46
P/TBV Ratio	6.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.97
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.32.

Current Ratio	2.72
Quick Ratio	2.64
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.76

Financial Efficiency

Return on equity (ROE) is -64.31% and return on invested capital (ROIC) is -34.12%.

Return on Equity (ROE)	-64.31%
Return on Assets (ROA)	-28.94%
Return on Invested Capital (ROIC)	-34.12%
Return on Capital Employed (ROCE)	-91.60%
Revenue Per Employee	n/a
Profits Per Employee	-4.60M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.21%
50-Day Moving Average	4.45
200-Day Moving Average	3.97
Relative Strength Index (RSI)	50.54
Average Volume (20 Days)	257

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.50M
Pretax Income	-36.81M
Net Income	-36.81M
EBITDA	-38.29M
EBIT	-38.50M
Earnings Per Share (EPS)	-0.61

Full Income Statement

Balance Sheet

The company has 64.18 million in cash and 13.25 million in debt, giving a net cash position of 50.93 million.

Cash & Cash Equivalents	64.18M
Total Debt	13.25M
Net Cash	50.93M
Net Cash Per Share	n/a
Equity (Book Value)	41.97M
Book Value Per Share	0.70
Working Capital	41.74M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-34.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:137 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.88%
Shareholder Yield	-0.88%
Earnings Yield	-13.58%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1